Skin cancer is declining among younger adults in Sweden for the first time after decades of increases, making it the first European country to see a fall, researchers said on Monday.
Sep 9, 2024
0
0
Cellular immunotherapy, a leading form of cancer treatment, enlists the "warriors" of our immune system, our T-cells, in the war on cancer. During preparations for the treatment, doctors take a sample of T-cells from the ...
Sep 9, 2024
0
48
A new survey finds the majority of American men believe the first step in prostate cancer screening is an invasive rectal exam by their doctor.
Sep 9, 2024
0
1
A study published in Nature Machine Intelligence introduces an advanced artificial intelligence (AI) model capable of creating virtual colorations of cancer tissue. The study, co-led by scientists at the Universities of Lausanne ...
Sep 9, 2024
0
33
Research from Purdue University in collaboration with the National Institutes of Health (NIH) reveals that, thanks to a new computational tool, a cancer drug dismissed by traditional testing methods may be effective in treating ...
Sep 9, 2024
0
14
About 11,000 Asian American and Pacific Islander women were diagnosed with breast cancer in 2021 and about 1,500 died. The latest federal data shows the rate of new breast cancer diagnoses in Asian American and Pacific Islander ...
Sep 9, 2024
0
30
Cancer cells seldom start off stealthy. Quite to the contrary, they announce their presence to the immune system by planting chemical red flags right on their membranes. Once alerted, the body's defenses can swoop in, destroying ...
Sep 9, 2024
0
29
Researchers at the University of Michigan Health Rogel Cancer Center have uncovered a key reason that a typically normal protein goes awry and fuels cancer.
Sep 9, 2024
0
59
New research suggests that a family member's cancer diagnosis may increase first-degree relatives' and spouses' risks of developing psychological and cardiovascular illnesses. The findings are published in the journal Cancer.
Sep 9, 2024
0
0
Phase 2 results from the NeoCOAST-2 study have demonstrated that the combination of durvalumab with Dato-DXd yielded the highest pathological complete response rates among the tested regimens.
Sep 8, 2024
0
0
